Effectiveness of implantable cardioverter-defibrillators in patients with ischemic heart disease and left ventricular dysfunction

Archives of Internal Medicine

Volumn 166, Issue 20, 2006, Pages 2228-2233

  Chan, Paul S ^a,c   Chow, Theodore ^d   Kereiakes, Dean ^d   Schloss, Edward J ^d   Waller, Theodore ^d   Eagle, Kim ^a   Hayward, Rodney A ^b,c   Vijan, Sandeep ^b,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^d Ohio Heart and Vascular Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFIBRILLATOR; DEVICE; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HUMAN; ISCHEMIC HEART DISEASE; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; CHI-SQUARE DISTRIBUTION; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33751047573     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.20.2228     Document Type: Article

References (21)

1. Moss AJ, Zareba W, Hall WJ, et al; Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.
2. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
3. Moss AJ, Hall WJ, Cannom DS, et al; The Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-1940.
4. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G; The Multicenter Unsustained Tachycardia Trial Investigators. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882-1890.
5. Chan PS, Hayward RA. Mortality reduction by implantable cardioverter-defibrillators in high-risk patients with heart failure, ischemic heart disease, and new-onset ventricular arrhythmia: an effectiveness study. J Am Coll Cardiol. 2005;45:1474-1481.
6. Ong AT, Hoye A, Aoki J, et al. Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947-953.
7. Al-Khatib SM, Lucas FL, Jollis JG, Malenka DJ, Wennberg DE. The relation between patients' outcomes and the volume of cardioverter-defibrillator implantation procedures performed by physicians treating Medicare beneficiaries. J Am Coll Cardiol. 2005;46:1536-1540.
8. Reynolds MR, Cohen DJ, Kugelmass AD, et al. The frequency and incremental cost of major complications among Medicare beneficiaries receiving implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2493-2497.
9. Phurrough S, Salive M, Baldwin J, Chin J. Decision summary: implantable cardioverter-defibrillators (CAG 00157R2). December 28, 2004. http://www.cms.hhs.gov/mcd/viewncd.asp?ncd_id=20.4&ncd_version=2&basket= ncd%3A20%2E4%3A2%3AImplantable+Automatic+Defibrillators.). Accessed March 21, 2005.
10. Al-Khatib SM, Anstrom KJ, Eisenstein EL, et al. Clinical and economic implications of the Multicenter Automatic Defibrillator Implantation Trial-II. Ann Intern Med. 2005;142:593-600.
11. Chan PS, Stein K, Chow T, Fendrick AM, Bigger JT Jr, Vijan S. Costeffectiveness of a microvolt t-wave alternans screening strategy for ICD placement in the MADIT-II eligible population. J Am Coll Cardiol. 2006;48:112-21.
12. Centers for Medicare & Medicaid Services. Medicare draft national coverage for implantable cardioverter-defibrillators includes registry of recipients to track progress. September 28, 2004. http://www.cms.hhs.gov/media/ press/release.asp?Counter=1212. Accessed March 21, 2005.
13. Bloomfield DM, Hohnloser SH, Cohen RJ. Interpretation and classification of microvolt T wave alternans tests. J Cardiovasc Electrophysiol. 2002;13:502-512.
14. Centers for Disease Control and Prevention. National Death Index User's Manual. Washington, DC: Dept of Vital Statistics, Centers for Disease Control and Prevention; 2003.
15. Rich-Edwards JW, Corsano KA, Stampfer MJ. Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol. 1994;140:1016-1019.
16. Hinkle LE Jr, Thaler HT. Clinical classification of cardiac deaths. Circulation. 1982;65:457-464.
17. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
18. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763.
19. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-524.
20. Sesselberg HW, Moss AJ, Steinberg J, et al. Factors associated with ventricular inducibility in the MADIT-II study population. Am J Cardiol. 2003;91:1002-1004.
21. Moss AJ. MADIT-II: substudies and their implications. Card Electrophysiol Rev. 2003;7:430-433.